Thomas G. Auchincloss
Director/Board Member bij Kieve Affective Education, Inc.
Oorsprong van het eerstegraads netwerk van Thomas G. Auchincloss
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Chemicals: Agricultural | 10 | |
Kieve Affective Education, Inc.
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas G. Auchincloss via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALBEMARLE CORPORATION | Chemicals: Specialty | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Ethyl Corp.
 Ethyl Corp. Industrial SpecialtiesProcess Industries Ethyl Corp. provides blending and supply solutions. The firm supplies gasoline performance additives and diesel cetane improvers. It also offers terminal, storage, and trans loading services. The company was founded on February 15, 1887 and is headquartered in Richmond, VA. | Industrial Specialties | Corporate Officer/Principal | |
| GRAHAM CORPORATION | Industrial Machinery | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Ondax, Inc.
 Ondax, Inc. Medical SpecialtiesHealth Technology Ondax, Inc. designs, manufactures and markets holographic optical filters and wavelength-stabilized laser sources. It products include wavelength stabilization gratings, low-frequency spectroscopy systems, wavelength stabilized lazers, ultra-narrowband notch filters and assemblies, ASE filters, beamsplitters and lasers, and pulse stretcher and compressor filters. The company was founded by Christophe Moser, Karsten Buse and Demetri Psaltis in July 2000 and is headquartered in Duarte, CA. | Medical Specialties | Chairman | |
AdipoGenix, Inc.
 AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prolacta Bioscience, Inc.
 Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Pharmaceuticals: Other | Director/Board Member | |
Tepha, Inc.
 Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member Founder | |
| RADIUS HEALTH, INC. | Biotechnology | Founder | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Agrivida, Inc.
 Agrivida, Inc. BiotechnologyHealth Technology Agrivida, Inc. engages in the provision of research and manufacture of enzymes. It focuses on enzymes that improve poultry and swine nutrition. The company was founded by R. Michael Raab and Jeremy Schley Johnson in 2002 and is headquartered in Medford, MA. | Biotechnology | Director/Board Member | |
| UNIVERSAL SOLAR TECHNOLOGY INC | Financial Conglomerates | Chief Executive Officer | |
Boka Sciences, Inc
 Boka Sciences, Inc BiotechnologyHealth Technology Boka Sciences, Inc provides biotechnology services. It develops human hydration assessment tests using biomarkers. The company was founded by Andrew Byars and is headquartered in Santa Barbara, CA. | Biotechnology | Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
GelTech, Inc.
 GelTech, Inc. Home FurnishingsConsumer Durables Part of LightPath Technologies, Inc., GelTech, Inc. manufactures precision molded aspherical optics used in the active telecom components market. The private company is based in Orlando, FL. GelTech was acquired by LightPath Technologies, Inc. on September 22, 2000 for $36.10 million. | Home Furnishings | President | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Masters Business Admin | |
| New York University | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Robert W. Baird & Co., Inc. /Venture Partners/
 Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Robert W. Baird & Co., Inc./Venture Partners/ (Baird Venture) is a venture capital division of Robert W. Baird & Co., Inc. founded in 2000 by Thomas Desmond. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
Arcturus Capital LLC
 Arcturus Capital LLC Investment ManagersFinance Arcturus Capital LLC (Arcturus Capital) is a venture capital firm founded in 2000 by Stephen H Watkins. The firm is headquartered in Pasadena, California. | Investment Managers | Founder | |
Accelerated Cure Project for Multiple Sclerosis
 Accelerated Cure Project for Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services The Accelerated Cure Project for Multiple Sclerosis cures multiple sclerosis (MS) by determining the cause. It specializes in research, biobanking, collaboration, fundraising, nonprofit. The company was founded by Art Mellor in 2000 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
| Barber Advisors LLC | Corporate Officer/Principal | ||
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Miscellaneous Manufacturing | Chief Operating Officer | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| Trigenics Technology, Inc. | Founder |
Statistieken
Internationaal
| Verenigde Staten | 50 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 11 |
| Finance | 9 |
| Process Industries | 3 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 215 |
| Corporate Officer/Principal | 98 |
| Independent Dir/Board Member | 40 |
| Chairman | 39 |
| Founder | 38 |
Sterkste connecties
| Insiders | |
|---|---|
| Douglas Cole | 44 |
| Charlie Sanders | 38 |
| Bruce Sachs | 35 |
| Richard H. Aldrich | 31 |
| Wei Li | 24 |
| Robert van Nostrand | 22 |
| Peter Kellogg | 21 |
| James Barber | 20 |
| Pravin Ramsewak Chaturvedi | 19 |
| Thierry Hercend | 18 |
| Julius Knowles | 17 |
| Matthew Strobeck | 15 |
| Stephen H. Watkins | 15 |
| John Alam | 14 |
| Iain Peter Murray Buchanan | 13 |
- Beurs
- Insiders
- Thomas G. Auchincloss
- Bedrijfsconnecties
